iBio, Inc. (IBIO) Financials

IBIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 99.1 million 13.4 million
March 31, 2026 85.8 million 8.3 million
Dec. 31, 2025 64.4 million 7.8 million
Sept. 30, 2025 64.2 million 8.1 million

IBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.2 million 420000
March 31, 2026 -6.1 million 377000
Dec. 31, 2025 -5.8 million 253000
Sept. 30, 2025 -5.7 million 323000

IBIO Net Income

No data available :(

IBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 88.0 million - 2.2 million
March 31, 2026 74.8 million - 1.8 million
Dec. 31, 2025 52.7 million - 2.5 million
Sept. 30, 2025 49.6 million - 2.6 million

IBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 104.1 million
March 31, 2026 119.6 million
Dec. 31, 2025 99.1 million
Sept. 30, 2025 53.0 million

IBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 19000 8.6 million -2.2 million -
March 31, 2026 11000 3.3 million 5.1 million -
Dec. 31, 2025 516000 4.3 million 5.2 million -
Sept. 30, 2025 32000 3.6 million 2.5 million -

IBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -780000
March 31, 2026 - 250000
Dec. 31, 2025 - 241000
Sept. 30, 2025 100000 289000

IBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IBIO

Price: $1.19

52 week price:
0.77
3.82

Earnings Per Share: -0.32 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.7 million

Market Capitalization: 64.6 million

Links: